Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Thinking Inside the Box: Synovial Tissue Biopsy in Immune Checkpoint Inhibitor-Induced Arthritis.

Medina HA, Eickhoff J, Edison JD.

J Clin Rheumatol. 2019 May 24. doi: 10.1097/RHU.0000000000001088. [Epub ahead of print] No abstract available.

PMID:
31136415
2.

Autoantibodies are present before the clinical diagnosis of systemic sclerosis.

Burbelo PD, Gordon SM, Waldman M, Edison JD, Little DJ, Stitt RS, Bailey WT, Hughes JB, Olson SW.

PLoS One. 2019 Mar 26;14(3):e0214202. doi: 10.1371/journal.pone.0214202. eCollection 2019.

3.

Risk Factors for Future Scleroderma Renal Crisis at Systemic Sclerosis Diagnosis.

Gordon SM, Stitt RS, Nee R, Bailey WT, Little DJ, Knight KR, Hughes JB, Edison JD, Olson SW.

J Rheumatol. 2019 Jan;46(1):85-92. doi: 10.3899/jrheum.171186. Epub 2018 Jul 15.

PMID:
30008456
4.

Combination of anti-citrullinated protein antibodies and rheumatoid factor is associated with increased systemic inflammatory mediators and more rapid progression from preclinical to clinical rheumatoid arthritis.

Lingampalli N, Sokolove J, Lahey LJ, Edison JD, Gilliland WR, Holers VM, Deane KD, Robinson WH.

Clin Immunol. 2018 Oct;195:119-126. doi: 10.1016/j.clim.2018.05.004. Epub 2018 May 26.

PMID:
29842946
5.

Triple Positivity for Anti-Citrullinated Protein Autoantibodies, Rheumatoid Factor, and Anti-Carbamylated Protein Antibodies Conferring High Specificity for Rheumatoid Arthritis: Implications for Very Early Identification of At-Risk Individuals.

Verheul MK, Böhringer S, van Delft MAM, Jones JD, Rigby WFC, Gan RW, Holers VM, Edison JD, Deane KD, Janssen KMJ, Westra J, Brink M, Rantapää-Dahlqvist S, Huizinga TWJ, van der Helm-van Mil AHM, van der Woude D, Toes REM, Trouw LA.

Arthritis Rheumatol. 2018 Nov;70(11):1721-1731. doi: 10.1002/art.40562. Epub 2018 Sep 16.

PMID:
29781231
6.

Anti-Myeloperoxidase Antibodies Associate with Future Proliferative Lupus Nephritis.

Olson SW, Lee JJ, Poirier M, Little DJ, Prince LK, Baker TP, Edison JD, Abbott KC.

Autoimmune Dis. 2017;2017:1872846. doi: 10.1155/2017/1872846. Epub 2017 Dec 24.

7.

An Unusual Case of a Swollen Elbow.

Stitt R, Edison JD, Tracy C.

Arthritis Rheumatol. 2016 Dec;68(12):3046. doi: 10.1002/art.39949. No abstract available.

8.

Iatrogenic Thenar Eminence Atrophy After Botox A Injection for Secondary Raynaud Phenomenon.

Eickhoff JC, Smith JK, Landau ME, Edison JD.

J Clin Rheumatol. 2016 Oct;22(7):396-7. doi: 10.1097/RHU.0000000000000450. No abstract available.

PMID:
27660946
9.

IMAGES IN CLINICAL MEDICINE. Milk of Urate Bulla.

Robbins RC, Edison JD.

N Engl J Med. 2016 Jul 14;375(2):162. doi: 10.1056/NEJMicm1512068. No abstract available.

10.

Anti-carbamylated protein antibodies are present prior to rheumatoid arthritis and are associated with its future diagnosis.

Gan RW, Trouw LA, Shi J, Toes RE, Huizinga TW, Demoruelle MK, Kolfenbach JR, Zerbe GO, Deane KD, Edison JD, Gilliland WR, Norris JM, Holers VM.

J Rheumatol. 2015 Apr;42(4):572-9. doi: 10.3899/jrheum.140767. Epub 2015 Jan 15.

11.

Performance of anti-cyclic citrullinated Peptide assays differs in subjects at increased risk of rheumatoid arthritis and subjects with established disease.

Demoruelle MK, Parish MC, Derber LA, Kolfenbach JR, Hughes-Austin JM, Weisman MH, Gilliland W, Edison JD, Buckner JH, Mikuls TR, O'Dell JR, Keating RM, Gregersen PK, Norris JM, Holers VM, Deane KD.

Arthritis Rheum. 2013 Sep;65(9):2243-52. doi: 10.1002/art.38017.

12.

Progress toward personalized treatment of rheumatoid arthritis.

Keith MP, Edison JD, Gilliland WR.

Clin Pharmacol Ther. 2012 Oct;92(4):440-2. doi: 10.1038/clpt.2012.124. Epub 2012 Aug 22. Review.

PMID:
22910444
13.

Autoantibody epitope spreading in the pre-clinical phase predicts progression to rheumatoid arthritis.

Sokolove J, Bromberg R, Deane KD, Lahey LJ, Derber LA, Chandra PE, Edison JD, Gilliland WR, Tibshirani RJ, Norris JM, Holers VM, Robinson WH.

PLoS One. 2012;7(5):e35296. doi: 10.1371/journal.pone.0035296. Epub 2012 May 25. Erratum in: PLoS One.doi: 10.1371/annotation/2e462817-ab93-4d78-95a4-1d8b9d172971.

14.

Optimizing therapeutics: the next front in the war on rheumatoid arthritis.

Edison JD, Gilliland WR.

Clin Pharmacol Ther. 2012 Apr;91(4):561-6. doi: 10.1038/clpt.2012.8. No abstract available.

PMID:
22434026
15.

The number of elevated cytokines and chemokines in preclinical seropositive rheumatoid arthritis predicts time to diagnosis in an age-dependent manner.

Deane KD, O'Donnell CI, Hueber W, Majka DS, Lazar AA, Derber LA, Gilliland WR, Edison JD, Norris JM, Robinson WH, Holers VM.

Arthritis Rheum. 2010 Nov;62(11):3161-72. doi: 10.1002/art.27638.

16.

Autoimmunity to peptidyl arginine deiminase type 4 precedes clinical onset of rheumatoid arthritis.

Kolfenbach JR, Deane KD, Derber LA, O'Donnell CI, Gilliland WR, Edison JD, Rosen A, Darrah E, Norris JM, Holers VM.

Arthritis Rheum. 2010 Sep;62(9):2633-9. doi: 10.1002/art.27570.

17.

Gemcitabine-associated large vessel vasculitis presenting as fever of unknown origin.

Ramsay LB, Stany MP, Edison JD, Bernstein SA, Schlegal KE, Hamilton CA.

J Clin Rheumatol. 2010 Jun;16(4):181-2. doi: 10.1097/RHU.0b013e3181df91ad.

PMID:
20407388
18.

The Clinical Picture - Soft tissue atrophy after corticosteroid injection.

Papadopoulos PJ, Edison JD.

Cleve Clin J Med. 2009 Jun;76(6):373-4. doi: 10.3949/ccjm.76a.08096. No abstract available.

PMID:
19487559

Supplemental Content

Loading ...
Support Center